Description of Changes in NIRS as a Function of Ductus Arteriosus Status in Very Premature Babies Born Before 32 WG at the DIJON University Hospital
NCT ID: NCT06153771
Last Updated: 2025-09-24
Study Results
The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.
Basic Information
Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.
COMPLETED
26 participants
OBSERVATIONAL
2023-10-16
2024-09-14
Brief Summary
Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.
NIRS (near-infrared spectroscopy) is a non-invasive method of monitoring tissue oxygen saturation using infrared light.
The aim of the study was to investigate an association between cerebral and renal NIRS data and ductus arteriosus status obtained by echocardiography.
Related Clinical Trials
Explore similar clinical trials based on study characteristics and research focus.
Evaluation of the Brain and Renal Regional Oxygenation Using NIRS in Preterm Infants
NCT04295395
NIRS in PDA VLBW Infants
NCT02396004
Monitoring of Systemic or Organ Perfusion for Preterm Infants
NCT03136172
NIRS in Neonatal Cardiac Surgery
NCT00166101
Monitoring of Cerebral and Abdominal Tissue Oxygen Saturation in Neonates
NCT03149731
Detailed Description
Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.
Conditions
See the medical conditions and disease areas that this research is targeting or investigating.
Study Design
Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.
COHORT
PROSPECTIVE
Study Groups
Review each arm or cohort in the study, along with the interventions and objectives associated with them.
Extremely premature newborn
(born before 32 weeks' gestation)
Collection of brain and kidney NIRS measurements
(recorded continuously) by a person not involved in the study 30 minutes before echocardiography was performed
echocardiography
on day 2, day 4 and day 7 of life
Interventions
Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.
Collection of brain and kidney NIRS measurements
(recorded continuously) by a person not involved in the study 30 minutes before echocardiography was performed
echocardiography
on day 2, day 4 and day 7 of life
Eligibility Criteria
Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.
Inclusion Criteria
* Very premature newborn (born before 32 weeks' gestation)
* Hospitalised in the Neonatal Intensive Care Unit at Dijon University Hospital
* Before 48 hours of life
Exclusion Criteria
* Newborn with a congenital renal anomaly
* Newborn with polymalformative syndrome
* Newborn with a skin anomaly
* Newborn with severe circulatory failure unrelated to the ductus arteriosus
48 Hours
ALL
Yes
Sponsors
Meet the organizations funding or collaborating on the study and learn about their roles.
Centre Hospitalier Universitaire Dijon
OTHER
Responsible Party
Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.
Locations
Explore where the study is taking place and check the recruitment status at each participating site.
Chu Dijon Bourgogne
Dijon, , France
Countries
Review the countries where the study has at least one active or historical site.
Other Identifiers
Review additional registry numbers or institutional identifiers associated with this trial.
TERNOY-Carriat 2023
Identifier Type: -
Identifier Source: org_study_id
More Related Trials
Additional clinical trials that may be relevant based on similarity analysis.